Natixis Advisors LLC trimmed its position in shares of Koninklijke Philips N.V. (NYSE:PHG - Free Report) by 3.1% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 718,269 shares of the technology company's stock after selling 23,008 shares during the period. Natixis Advisors LLC owned approximately 0.08% of Koninklijke Philips worth $18,244,000 as of its most recent SEC filing.
A number of other hedge funds also recently bought and sold shares of PHG. LPL Financial LLC boosted its holdings in Koninklijke Philips by 12.1% during the fourth quarter. LPL Financial LLC now owns 99,911 shares of the technology company's stock valued at $2,530,000 after acquiring an additional 10,766 shares during the period. Orion Portfolio Solutions LLC lifted its stake in shares of Koninklijke Philips by 38.2% in the fourth quarter. Orion Portfolio Solutions LLC now owns 13,497 shares of the technology company's stock valued at $342,000 after buying an additional 3,731 shares during the period. Arrowstreet Capital Limited Partnership lifted its stake in shares of Koninklijke Philips by 107.9% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 129,624 shares of the technology company's stock valued at $3,282,000 after buying an additional 67,289 shares during the period. O Shaughnessy Asset Management LLC lifted its stake in shares of Koninklijke Philips by 6.0% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 29,533 shares of the technology company's stock valued at $748,000 after buying an additional 1,671 shares during the period. Finally, Huntington National Bank lifted its stake in shares of Koninklijke Philips by 1,582.6% in the fourth quarter. Huntington National Bank now owns 4,745 shares of the technology company's stock valued at $120,000 after buying an additional 4,463 shares during the period. 13.67% of the stock is currently owned by institutional investors.
Koninklijke Philips Price Performance
Shares of NYSE PHG traded down $0.14 during mid-day trading on Wednesday, hitting $26.24. 439,477 shares of the stock were exchanged, compared to its average volume of 1,006,386. The company has a market cap of $25.26 billion, a P/E ratio of 138.08, a PEG ratio of 0.73 and a beta of 0.75. The stock's fifty day simple moving average is $24.18 and its two-hundred day simple moving average is $24.99. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.81 and a current ratio of 1.26. Koninklijke Philips N.V. has a twelve month low of $21.48 and a twelve month high of $32.91.
Koninklijke Philips (NYSE:PHG - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The technology company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.12. The company had revenue of $5.05 billion during the quarter, compared to analyst estimates of $4.35 billion. Koninklijke Philips had a net margin of 1.00% and a return on equity of 11.95%. As a group, analysts forecast that Koninklijke Philips N.V. will post 1.63 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen lowered shares of Koninklijke Philips from a "buy" rating to a "hold" rating in a research report on Saturday. Two equities research analysts have rated the stock with a hold rating, two have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy".
Read Our Latest Stock Analysis on PHG
Koninklijke Philips Company Profile
(
Free Report)
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Featured Articles

Before you consider Koninklijke Philips, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Koninklijke Philips wasn't on the list.
While Koninklijke Philips currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.